Announcing HEORStrategies, the newest division of ToxStrategies LLC!
HEORStrategies provides robust, strategic health economics and outcomes research (HEOR) consulting services to pharma, biotech, and medical device clients!
Latest News
EpidStrategies’ Scientists are Presenting on RSV at IDWeek 2023
EpidStrategies’ scientists are recognized experts in the field of respiratory syncytial virus (RSV). Our RSV research program supported the newly-approved monoclonal antibody with… read more
New Publications Advance the Study of Cannabinoid Safety
ToxStrategies scientist Dr. Rayetta Henderson is among the authors of two new articles published by the journal Cannabis and Cannabinoid Research. Together, these… read more
ToxStrategies scientists publish study on potential dietary intake limits for cannabidiol (CBD)
ToxStrategies scientists have published a manuscript in the journal Regulatory Toxicology and Pharmacology reporting the outcome of a state-of-the-science assessment to develop recommendations… read more
Dr. Sampedro Joins ToxStrategies’ Foods and Consumer Products Practice
We are thrilled to announce that Dr. Fernando Sampedro has joined ToxStrategies LLC, bringing his broad expertise and depth of experience to our Foods… read more
Dr. Michael Kelsh joins EpidStrategies, a Division of ToxStrategies LLC
EpidStrategies, a Division of ToxStrategies LLC, is pleased to announce the addition of Dr. Michael Kelsh to our team, adding considerable depth to… read more
ToxStrategies scientists presenting at The Charles River Biotech Symposium
ToxStrategies scientists Marcie Wood, Ph.D. and Kirsten Mease, B.S. will be presenting at The Charles River Biotech Symposium – Biotechnology-Derived Therapeutics Perspectives on… read more
How are Decisions Made Regarding Safe Levels of Radiation in the Environment?
For more than a century, radiation health has been a concern for the public and for workers. However, the launch of the Hollywood… read more